Validated using a knockout cell line
Recombinant
RabMAb

Recombinant Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Loading Control (HRP) (ab194109)

Publishing research using ab194109? Please let us know so that we can cite the reference in this datasheet.

ab194109 has been referenced in 6 publications.

  • Zeng L  et al. A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-?B Signaling Pathways. Front Pharmacol 9:272 (2018). PubMed: 29662452
  • Xu Q  et al. Paeonol Reduces the Nucleocytoplasmic Transportation of HMGB1 by Upregulating HDAC3 in LPS-Induced RAW264.7 Cells. Inflammation N/A:N/A (2018). WB . PubMed: 29736733
  • Minashima T & Kirsch T Annexin A6 regulates catabolic events in articular chondrocytes via the modulation of NF-?B and Wnt/ß-catenin signaling. PLoS One 13:e0197690 (2018). PubMed: 29771996
  • Wang Y  et al. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/ß-catenin signal pathway in hepatocellular carcinoma. Cell Death Dis 9:851 (2018). PubMed: 30154476
  • Xiong Y  et al. Eph/ephrin signalling serves a bidirectional role in lipopolysaccharide-induced intestinal injury. Mol Med Rep 18:2171-2181 (2018). PubMed: 29901151
  • Wang C  et al. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/ß-catenin signaling pathways in hepatocellular and colorectal carcinoma cells. Oncotarget 8:1092-1109 (2017). WB ; Human . PubMed: 27901475

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up